Operationalizing 17α-Hydroxyprogesterone Caproate to Prevent Recurrent Preterm Birth: Definitions, Barriers, and Next Steps. Issue 6 (December 2016)
- Record Type:
- Journal Article
- Title:
- Operationalizing 17α-Hydroxyprogesterone Caproate to Prevent Recurrent Preterm Birth: Definitions, Barriers, and Next Steps. Issue 6 (December 2016)
- Main Title:
- Operationalizing 17α-Hydroxyprogesterone Caproate to Prevent Recurrent Preterm Birth
- Authors:
- Stringer, Elizabeth M.
Vladutiu, Catherine J.
Batra, Priya
Stringer, Jeffrey S. A.
Menard, M. Kathryn - Abstract:
- Abstract : Each year in the United States, more than 500, 000 neonates are born before 37 weeks of gestation. Women who have experienced a previous preterm birth are at high risk of recurrence. A weekly prenatal injection of 17α-hydroxyprogesterone caproate decreases the risk of recurrent preterm birth and is recommended from as early as 16 weeks of gestation in women carrying singleton pregnancies who have a history of spontaneous singleton preterm birth. A commonly used metric for public health program effectiveness is population coverage of an intervention. In the case of 17α-hydroxyprogesterone caproate, population coverage can be defined as the proportion of women who are eligible for 17α-hydroxyprogesterone caproate (ie, previous pregnancy complicated by spontaneous singleton preterm birth) who actually receive the intervention. To receive a full course of 17α-hydroxyprogesterone caproate, women must negotiate a complex series of steps that includes presenting early for prenatal care, being identified as eligible for 17α-hydroxyprogesterone caproate, being offered 17α-hydroxyprogesterone caproate, accepting 17α-hydroxyprogesterone caproate, and adhering to the weekly 17α-hydroxyprogesterone caproate dose schedule. We describe this series of steps as well potential solutions to increase 17α-hydroxyprogesterone caproate coverage. Abstract : 17α-hydroxyprogestone decreases the risk recurrent preterm birth, but its widespread use has foundered because of a complex set ofAbstract : Each year in the United States, more than 500, 000 neonates are born before 37 weeks of gestation. Women who have experienced a previous preterm birth are at high risk of recurrence. A weekly prenatal injection of 17α-hydroxyprogesterone caproate decreases the risk of recurrent preterm birth and is recommended from as early as 16 weeks of gestation in women carrying singleton pregnancies who have a history of spontaneous singleton preterm birth. A commonly used metric for public health program effectiveness is population coverage of an intervention. In the case of 17α-hydroxyprogesterone caproate, population coverage can be defined as the proportion of women who are eligible for 17α-hydroxyprogesterone caproate (ie, previous pregnancy complicated by spontaneous singleton preterm birth) who actually receive the intervention. To receive a full course of 17α-hydroxyprogesterone caproate, women must negotiate a complex series of steps that includes presenting early for prenatal care, being identified as eligible for 17α-hydroxyprogesterone caproate, being offered 17α-hydroxyprogesterone caproate, accepting 17α-hydroxyprogesterone caproate, and adhering to the weekly 17α-hydroxyprogesterone caproate dose schedule. We describe this series of steps as well potential solutions to increase 17α-hydroxyprogesterone caproate coverage. Abstract : 17α-hydroxyprogestone decreases the risk recurrent preterm birth, but its widespread use has foundered because of a complex set of patient- and system-level factors that are reviewed in this article. … (more)
- Is Part Of:
- Obstetrics and gynecology. Volume 128:Issue 6(2016)
- Journal:
- Obstetrics and gynecology
- Issue:
- Volume 128:Issue 6(2016)
- Issue Display:
- Volume 128, Issue 6 (2016)
- Year:
- 2016
- Volume:
- 128
- Issue:
- 6
- Issue Sort Value:
- 2016-0128-0006-0000
- Page Start:
- Page End:
- Publication Date:
- 2016-12
- Subjects:
- Obstetrics -- Periodicals
Gynecology -- Periodicals
618 - Journal URLs:
- http://journals.lww.com/greenjournal/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/AOG.0000000000001738 ↗
- Languages:
- English
- ISSNs:
- 0029-7844
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6208.200000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 1227.xml